Cargando…
Pfizer BNT 162b2 COVID-19 vaccine–induced fulminant myopericarditis: A case study
The use of mRNA COVID-19 vaccine can on rare occasions cause life-threatening, fulminant myopericarditis. This case report demonstrates previously reported benefit of early use of venoarterial extracorporeal membrane oxygenation mechanical assistance and supports the use of intravenous highly purifi...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581261/ https://www.ncbi.nlm.nih.gov/pubmed/37876367 http://dx.doi.org/10.1016/j.ccrj.2023.06.005 |
_version_ | 1785122103451713536 |
---|---|
author | Montarello, Natalie L. Wong, Hao Zheng Jeffries, Ashlee Perkins, Griffith B. Hissaria, Pravin Stokes, Michael B. Raith, Eamon Teo, Karen Bradley, Julie |
author_facet | Montarello, Natalie L. Wong, Hao Zheng Jeffries, Ashlee Perkins, Griffith B. Hissaria, Pravin Stokes, Michael B. Raith, Eamon Teo, Karen Bradley, Julie |
author_sort | Montarello, Natalie L. |
collection | PubMed |
description | The use of mRNA COVID-19 vaccine can on rare occasions cause life-threatening, fulminant myopericarditis. This case report demonstrates previously reported benefit of early use of venoarterial extracorporeal membrane oxygenation mechanical assistance and supports the use of intravenous highly purified immunoglobulin pharmacotherapy to help achieve a good clinical outcome. |
format | Online Article Text |
id | pubmed-10581261 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-105812612023-10-24 Pfizer BNT 162b2 COVID-19 vaccine–induced fulminant myopericarditis: A case study Montarello, Natalie L. Wong, Hao Zheng Jeffries, Ashlee Perkins, Griffith B. Hissaria, Pravin Stokes, Michael B. Raith, Eamon Teo, Karen Bradley, Julie Crit Care Resusc Case Report The use of mRNA COVID-19 vaccine can on rare occasions cause life-threatening, fulminant myopericarditis. This case report demonstrates previously reported benefit of early use of venoarterial extracorporeal membrane oxygenation mechanical assistance and supports the use of intravenous highly purified immunoglobulin pharmacotherapy to help achieve a good clinical outcome. Elsevier 2023-07-26 /pmc/articles/PMC10581261/ /pubmed/37876367 http://dx.doi.org/10.1016/j.ccrj.2023.06.005 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Montarello, Natalie L. Wong, Hao Zheng Jeffries, Ashlee Perkins, Griffith B. Hissaria, Pravin Stokes, Michael B. Raith, Eamon Teo, Karen Bradley, Julie Pfizer BNT 162b2 COVID-19 vaccine–induced fulminant myopericarditis: A case study |
title | Pfizer BNT 162b2 COVID-19 vaccine–induced fulminant myopericarditis: A case study |
title_full | Pfizer BNT 162b2 COVID-19 vaccine–induced fulminant myopericarditis: A case study |
title_fullStr | Pfizer BNT 162b2 COVID-19 vaccine–induced fulminant myopericarditis: A case study |
title_full_unstemmed | Pfizer BNT 162b2 COVID-19 vaccine–induced fulminant myopericarditis: A case study |
title_short | Pfizer BNT 162b2 COVID-19 vaccine–induced fulminant myopericarditis: A case study |
title_sort | pfizer bnt 162b2 covid-19 vaccine–induced fulminant myopericarditis: a case study |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581261/ https://www.ncbi.nlm.nih.gov/pubmed/37876367 http://dx.doi.org/10.1016/j.ccrj.2023.06.005 |
work_keys_str_mv | AT montarellonataliel pfizerbnt162b2covid19vaccineinducedfulminantmyopericarditisacasestudy AT wonghaozheng pfizerbnt162b2covid19vaccineinducedfulminantmyopericarditisacasestudy AT jeffriesashlee pfizerbnt162b2covid19vaccineinducedfulminantmyopericarditisacasestudy AT perkinsgriffithb pfizerbnt162b2covid19vaccineinducedfulminantmyopericarditisacasestudy AT hissariapravin pfizerbnt162b2covid19vaccineinducedfulminantmyopericarditisacasestudy AT stokesmichaelb pfizerbnt162b2covid19vaccineinducedfulminantmyopericarditisacasestudy AT raitheamon pfizerbnt162b2covid19vaccineinducedfulminantmyopericarditisacasestudy AT teokaren pfizerbnt162b2covid19vaccineinducedfulminantmyopericarditisacasestudy AT bradleyjulie pfizerbnt162b2covid19vaccineinducedfulminantmyopericarditisacasestudy |